Q&A session: Ischemic disease: the importance of choosing the right time and the right therapeutic approach Angina Symposia & Webinars Q&A session: Ischemic disease: the importance of choosing the right time and the right therapeutic approach Discussion of audience questions at the ESC Asia Virtual Congress 2020 with David KL Quek, Mario Marzilli and Chin Chee Tang.
The importance of timing and treatment approach: a practical case Angina Symposia & Webinars The importance of timing and treatment approach: a practical case A concise intervention of Chin Chee Tang starting from a clinical case that stresses the importance of early treatment.
Chronic Coronary Syndromes: What have we learned from ESC Guidelines 2020 and recent trials? Angina Symposia & Webinars Chronic Coronary Syndromes: What have we learned from ESC Guidelines 2020 and recent trials? Comprehensive presentation by Prof. Mario Marzilli about updated guidelines, revascularization, and identification of the precipitating mechanism(s) for a personalized therapy.
Q&A session: Single-pill combinations in the management of hypertension: evidence from new guidelines, practical benefits for both physicians and patients Hypertension Symposia & Webinars Q&A session: Single-pill combinations in the management of hypertension: evidence from new guidelines, practical benefits for both physicians and patients Neil Poulter and Rohit Khurana discussing audience questions at the ESC Asia Virtual Congress session.
Strictly following the Guidelines is the Key to Reaching Targets Hypertension Symposia & Webinars Strictly following the Guidelines is the Key to Reaching Targets Neil R Poulter discusses various options of combination therapy in Hypertension within the framework of the current guidelines.
Ischemic disease: the importance of choosing the right time and the right therapeutic approach – Introduction Angina Symposia & Webinars Ischemic disease: the importance of choosing the right time and the right therapeutic approach – Introduction A brief introduction to ischemic disease by David KL Quek underlining the importance of an optimal management of ischemic disease.
What does the evidence tell us about first-line dual combinations? Hypertension Symposia & Webinars What does the evidence tell us about first-line dual combinations? Dr Rohit Khurana speaks about the importance of blood pressure control, about treatment barriers and strategies as well as effects of ACEi and ARBs.
